Trobalt



Indications and Reactions:

Role Indications Reactions
Primary
Epilepsy 66.4%
Partial Seizures 17.8%
Product Used For Unknown Indication 6.6%
Temporal Lobe Epilepsy 2.6%
Frontal Lobe Epilepsy 1.4%
Convulsion 0.7%
Depression 0.7%
Petit Mal Epilepsy 0.7%
Tinnitus 0.5%
Abnormal Behaviour 0.2%
Acne 0.2%
Congenital Anomaly 0.2%
Endometriosis 0.2%
Post-traumatic Epilepsy 0.2%
Pulmonary Embolism 0.2%
Pyrexia 0.2%
Rasmussen Encephalitis 0.2%
Refractory Cytopenia With Multilineage Dysplasia And Ringed Sideroblasts 0.2%
Schizophreniform Disorder 0.2%
Vertigo 0.2%
Convulsion 21.1%
Urinary Retention 11.9%
Epilepsy 10.1%
Somnolence 6.4%
Sudden Unexplained Death In Epilepsy 6.4%
Tremor 4.6%
Cardiac Arrest 3.7%
Diarrhoea 3.7%
Drug Ineffective 3.7%
Vertigo 3.7%
Aphasia 2.8%
Fatigue 2.8%
Micturition Disorder 2.8%
Suicide Attempt 2.8%
Visual Impairment 2.8%
Vomiting 2.8%
Weight Decreased 2.8%
Acquired Epileptic Aphasia 1.8%
Anxiety 1.8%
Apraxia 1.8%
Secondary
Epilepsy 66.0%
Partial Seizures 24.5%
Product Used For Unknown Indication 7.5%
Status Epilepticus 1.9%
Diplopia 28.6%
Hepatocellular Injury 21.4%
Mental Impairment 14.3%
Convulsion 7.1%
Death 7.1%
Sudden Unexplained Death In Epilepsy 7.1%
Urinary Retention 7.1%
Weight Decreased 7.1%
Concomitant
Epilepsy 36.1%
Status Epilepticus 11.1%
Convulsion 8.3%
Depression 5.6%
Complex Partial Seizures 2.8%
Contraception 2.8%
Disseminated Intravascular Coagulation 2.8%
Gastric Disorder 2.8%
Heparin-induced Thrombocytopenia 2.8%
Infection 2.8%
Inflammation 2.8%
Magnesium Deficiency 2.8%
Parenteral Nutrition 2.8%
Partial Seizures 2.8%
Renal Disorder 2.8%
Sedation 2.8%
Thyroxine Decreased 2.8%
Tri-iodothyronine Decreased 2.8%
Fatigue 20.0%
Organic Erectile Dysfunction 20.0%
Pleural Effusion 20.0%
Rhabdomyolysis 20.0%
Urinary Retention 20.0%
Interacting
Early Infantile Epileptic Encephalopathy With Burst-suppression 60.0%
Partial Seizures 20.0%
Product Used For Unknown Indication 20.0%
Thirst 50.0%
Urinary Tract Infection Bacterial 50.0%